A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3.
about
TRIM5α and Species Tropism of HIV/SIVA prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDSImpact of TRIM5α in vivoADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challengeMacrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humansLv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to IntegrationMonocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studiesAutologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeysAnimal models for HIV/AIDS researchCorrelation of acute humoral response with brain virus burden and survival time in pig-tailed macaques infected with the neurovirulent simian immunodeficiency virus SIVsmmFGbGoing wild: lessons from naturally occurring T-lymphotropic lentivirusesTRIM5 alpha drives SIVsmm evolution in rhesus macaques.Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.Menin mediates Tat-induced neuronal apoptosis in brain frontal cortex of SIV-infected macaques and in Tat-treated cells.Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new speciesViral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia.Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIVRecombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.Characterization of a macaque recombinant monoclonal antibody that binds to a CD4-induced epitope and neutralizes simian immunodeficiency virusIntrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replicationProtection by live, attenuated simian immunodeficiency virus against heterologous challenge.Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)).Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organizationNonprogressive and progressive primate immunodeficiency lentivirus infections.Use of molecular beacons for rapid, real-time, quantitative monitoring of cytotoxic T-lymphocyte epitope mutations in simian immunodeficiency virusA structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins.Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs.Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeysInfectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivoDiversity of envelope genes from an uncloned stock of SIVmac251.Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.Laser capture microdissection assessment of virus compartmentalization in the central nervous systems of macaques infected with neurovirulent simian immunodeficiency virusUnique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5.The ITAM in Nef influences acute pathogenesis of AIDS-inducing simian immunodeficiency viruses SIVsm and SIVagm without altering kinetics or extent of viremiaAPOBEC3G polymorphism as a selective barrier to cross-species transmission and emergence of pathogenic SIV and AIDS in a primate host.Evidence for cFMS signaling in HIV production by brain macrophages and microglia.Cell tropism of simian immunodeficiency virus in culture is not predictive of in vivo tropism or pathogenesisTRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques
P2860
Q24304062-97D4D43F-2B7B-4008-992E-5F66EDE4AC8CQ24803530-7D341F8E-B824-4CC0-B1DA-64485515F63EQ26786870-BF6857D9-1A28-411F-BEAF-F058A2FB9111Q27342615-4D4D1B3A-B47D-4401-8F1D-849E5870E1A0Q28345408-43FF17CA-4F6E-4750-8129-1C465B128565Q28546614-C9BF97AF-4416-41E0-9003-E04FD8D73A36Q28751900-3EBA9DAF-DBA5-40F4-AAAB-24AE4727B941Q28751926-48F0956A-E3E2-410B-86D3-89FDBC9F598DQ30423656-F6D46F25-FB6C-4771-8E35-9CD9DD561AE8Q30478136-2D114A1D-D5B5-493A-A254-752271760BB4Q31066870-17F402CA-B4C6-44B5-9EDC-A90E445E0CD4Q31129854-49337969-551D-437B-A125-29946814EDF8Q32157141-E26DF6F1-6D73-4343-BCB8-84B8561D9185Q33566813-CD553D04-6022-4EEC-BD6E-78B9D2E837CFQ33638458-EEC19949-88AD-4B5F-A370-A38DB1FFE274Q33680119-ABA4D878-76BC-4010-A606-EC81A1627246Q33783429-2901AB6C-FDB0-4BC3-A1A0-B2B9437959A9Q33800033-94D0D773-6BE7-4538-90E9-FDEAF8765E49Q33800760-CABC95EF-9328-4C7E-8EA4-234765863578Q33809225-957163DE-14CD-4A74-921D-DD89EAA65D68Q33811266-237C5DDD-515A-432C-9F44-A1899C3FBA11Q33820014-D6E0601F-4B33-49F0-95DF-48993D184BF7Q33840048-D774A98C-7A50-4780-97D5-3684DC320774Q33845764-B1E04149-31C6-4BE5-B8B3-43E55652D3E0Q33958988-47CC357B-0D2A-4D9E-B970-4499E722514DQ33996001-8A340DFC-9D6E-4197-9420-4F07C1D9FA00Q34042364-44661F0C-7B97-441C-8817-A4640FEC51CDQ34243491-1F77E274-2F42-4A8B-9FE6-0523FBECB116Q34278020-6FACD07E-FBD7-4983-8799-68FD3E3E0A7DQ34290999-323E6507-E519-429A-8915-09D1B5E749C1Q34302179-DD9FE625-C5DA-4748-A8AD-6ACC71705C20Q34315382-3E64B0C0-FD8C-4180-BD43-21D0BD5A6DE6Q34553778-BA69D6C5-B9E6-4C28-8690-DCF8D9026649Q34747341-1A37B9F6-66FC-4FD6-B8EC-9C49D3C8DD21Q34996824-7EE0B925-101B-4D66-AE44-9EBB0A566A41Q34998613-5D12B63A-D54D-4F51-86B7-5CE09D2A845DQ35008780-5A9C8B12-BE57-4945-B27F-3EB155907A27Q35009692-32D47EF8-F90A-43FC-8F86-9FC1DEBD4A77Q35103497-7216FAC0-A0CC-4C0F-BAF3-33FB565FB310Q35115622-AC6E8F7C-6D86-48A0-B33B-ABBE3AD0AD59
P2860
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
A molecularly cloned, pathogen ...... deficiency virus, SIVsmE543-3.
@ast
A molecularly cloned, pathogen ...... deficiency virus, SIVsmE543-3.
@en
type
label
A molecularly cloned, pathogen ...... deficiency virus, SIVsmE543-3.
@ast
A molecularly cloned, pathogen ...... deficiency virus, SIVsmE543-3.
@en
prefLabel
A molecularly cloned, pathogen ...... deficiency virus, SIVsmE543-3.
@ast
A molecularly cloned, pathogen ...... deficiency virus, SIVsmE543-3.
@en
P2093
P2860
P1433
P1476
A molecularly cloned, pathogen ...... odeficiency virus, SIVsmE543-3
@en
P2093
B Campbell
D Adger-Johnson
D C Montefiori
S Goldstein
W R Elkins
P2860
P304
P407
P577
1997-02-01T00:00:00Z